A Study to Investigate APL-4098 Alone and/or in Combination With Azacitidine in R/R AML and High-Risk MDS

Conditions: Acute Myeloid Leukemia Refractory; Myelodysplastic Syndrome Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts; Acute Myeloid Leukemia, in Relapse Interventions: Drug: APL-4098; Drug: Azacitidine and APL-4098 Sponsors: Apollo Therapeutics Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials